The significant impact of DGAT1 antagonism on melanoma cell proliferation and survival, exacerbated under conditions mimicking tumor microenvironmental stresses, highlights DGAT1 as a possible therapeutic target in melanoma. Here, DGAT1 is linked to neoplasm.